Chinese Journal of Experimental Traditional Medical Formulae
Content Determination of Ginsenoside Rg1, Ginsenoside Re and Ginsenoside Rb1 in Shenmai Injection by UPLC
Author:
Affiliation:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
    Abstract:

    Objective: To establish a method to determine the content of ginsenoside Rg1, ginsenoside Re and ginsenoside Rb1 in Shenmai injection by ultra performance liquid chromatography(UPLC). Method: ACQUITY® UPLC HSS T3 column (2.1 mm×50 mm, 1.8 μm)was used with mobile phase consisted of acetonitrile (A)-0.05% phosphoric acid solution (B) by gradient elution (0-5 min, 19%A;5-12 min, 19%-28%A;12-18 min, 28%-40%A) at a flow rate of 0.3 mL·min-1;the wavelength of detector was 203 nm. Result: Ginsenoside Rg1, ginsenoside Re and ginsenoside Rb1had good linearity within the range of 0.020 96-0.209 6, 0.017 64-0.176 4, 0.023 88-0.238 8 g·L-1 respectively. The average recoveries(n=6)were 100.12%, 100.08%, 99.51% and RSDs were 1.60%, 2.03%, 1.15% respectively. Conclusion: UPLC method may greatly improve the separation efficiency and analysis speed in the case of ginsenoside Rg1, ginsenoside Re and ginsenoside Rb1 in Shenmai injection while reducing the solvent consumption. As an alternative of conventional HPLC, UPLC is more convenient, rapid, accurate and excellent repeatability.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 29,2013
  • Revised:
  • Adopted:
  • Online: April 16,2014
  • Published:

Address:

Postcode:100700

Phone:010-84076882

E-mail:syfjx_2010@188.com

® 2024 All Rights Reserved

Supported by:Beijing E-Tiller Technology Development Co., Ltd.